Bally Technologies (BYI) Misses Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts BYI Hot Sheet
Price: $83.27 --0%
Financial Fact:
Research and development costs: 34.43M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Research and development costs: 34.43M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Bally Technologies (NYSE: BYI) reported Q3 EPS of $1.10, $0.02 worse than the analyst estimate of $1.12. Revenue for the quarter came in at $338 million versus the consensus estimate of $328.8 million.
For earnings history and earnings-related data on Bally Technologies (BYI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Nebius Group (NBIS) PT Raised to $300 at Compass Point
- Pyxis Oncology, Inc. (PYXS) Misses Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
